Risk Factors Affecting Complications Due to Prostate Biopsy
Journal Title: Üroonkoloji Bülteni - Year 2019, Vol 18, Issue 2
Abstract
Objective: Currently, transrectal ultrasound (TRUS) guided prostate biopsy is the standard method used for prostate cancer detection. In the last decade, hospitalization due to complications has increased, especially due to infectious causes. Therefore, it is important to determine the risk factors affecting the complications of prostate biopsy. Materials and Methods: One hundred and sixty-four patients who underwent TRUS-guided prostate biopsy due to prostate cancer suspicion were included in our study. Patients’ ages, total and free prostate specific antigen (PSA) levels, prostate volumes, digital rectal examination findings, level of education, pathology results and pain related to the procedure were recorded. A 10-cm long visual analogue scale (VAS) was used to assess the pain of the patients. Complications related to the procedure were questioned firstly on the same day and secondly during the visit of the patient for pathology. As a result of these evaluations, complications divided into three groups as none, minor (no intervention) and major (medically or surgically treated). Results: In our study, minor complications included rectal bleeding in 42 patients and hematuria lasting longer than 48 hours in 11 patients. Major complications were fever of >38 °C in two patients and epididymitis in one patient. There was no statistically significant effect of age, total and free PSA, prostate volume, level of education, digital rectal examination findings and pathology results on complications. There was no statistically significant relationship between VAS pain score and rectal bleeding, hematuria, epididymitis. On the other hand, a statistically significant relationship was found between VAS pain score and fever. Conclusion: In the limited number of studies on the determination of risk factors for complications associated with prostate biopsy, the level of education, digital rectal examination findings, and pain due to the procedure were evaluated. In the light of our results, we believe that patients with high pain scores may be at risk for complications, especially for fever.
Authors and Affiliations
Sinan Avcı, Sedat Öner, Efe Önen, Volkan Çağlayan, Metin Kılıç, Murat Şambel
Keywords
Related Articles
- EP ID EP588892
- DOI 10.4274/uob.galenos.2018.1149
- Views 99
- Downloads 0
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These blad...
Predicting Lamina Propria Invasion in Patients with Nonmuscle- invasive Bladder Cancer: Do RDW and NLR Really Work?
Objective: To determine the role of preoperative neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW) in predicting lamina propria invasion in bladder cancer. Materials and Methods: Eighty-eight pat...
Controversies in Radical Cystectomy: Meta-Analysis and Systemic Comparison of Open Surgery with Laparoscopic and Robotic Surgery
Open radical cystectomy (ORC) is the standard treatment modality in high-risk non-muscle-invasive and invasive bladder carcinoma. Although it has some advantages, oncologic outcomes of ORC are associated with high morbid...
Information about Prostate Cancer for Urologist: Ga-68 Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Scintigraphy
Recently, prostate-specific membrane antigen (PSMA), a glutamate carboxypeptidase II enzyme, has transformed intoan excited radiopharmaceutical agent as a result of radiolabeling of small peptides that are developed for...
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Since intravesical Bacillus Calmette-Guerin (BCG) began to be used for bladder cancer, our understanding of the importance of immune mechanisms in bladder cancer has steadily grown. With developments in immunotherapy in...